
Last updated: 2026-10-29 · Written by: SaiyanMed Research Team · Reading time: about 22 minutes · Scope: in-vitro laboratory handling of a research reagent
Related research products: ARA290 and ARA Water (PBS), the PBS reconstitution solvent for ARA-290. For laboratory research use only.
Quick answer: ARA-290 (cibinetide, pGlu-EQLERALNSS, C51H84N16O21, 1257.3 g/mol) is an acidic peptide. Its N-terminus is a pyroglutamate lactam, so it has no free amine. That leaves one arginine against two glutamates and the C-terminal carboxyl.[5][6] By our calculation its isoelectric point (pI) is 3.1–3.8 depending on the pKa set, and it carries about −2 net charge at pH 6.5–8. Acidic or unbuffered diluents drive it toward the pI, which is why it hazes or leaves “snow”. The fix is a buffer that holds pH ≥ 6.5 after the peptide is in. Phosphate is the natural choice, and a published formulation vehicle used 20 mM sodium phosphate at pH 6.5.[7] The detail almost nobody mentions is buffer capacity. By our calculation, 10 mg of acetate-salt peptide in 1 mL of ordinary 1× PBS can pull the pH from 7.4 down to about 4.4–4.6, right back into the cloudy zone. Supplier data agree with this picture: MedChemExpress reports 66.67 mg/mL in water adjusted to pH 8 with ammonia, but only 2.5 mg/mL in plain PBS, and that needed sonication and 37 °C.[1][2]
Key takeaways
- It is a charge problem, not a hydrophobicity problem. ARA-290 has no aromatic residues, no cysteine and only two leucines. Its calculated pI is 3.1–3.8, and its charge falls from −2 at pH 6.5 to about 0 near pH 3–3.5.
- Acid is exactly wrong. The acetic-acid trick that rescues basic peptides such as AOD9604 moves ARA-290 toward its pI.
- Phosphate works because it is a buffer in the right range. Its pKa2 is about 6.9–7.2, so it buffers best at pH 6.5–7.8. Sodium and potassium salts behave the same at the bench but differ on freezing.
- Buffer strength matters as much as pH. The peptide’s own carboxyl groups release protons as they ionise. At ≥ 5 mg/mL, 1× PBS (about 12 mM phosphate) is overwhelmed; 50–100 mM phosphate holds the pH. These are our calculations, and the method is shown below.
- Measure the pH after dissolution. That one reading explains most failed vials.
- Clear is not the same as intact. The Asn9–Ser10 bond is a known deamidation and cleavage hotspot at neutral to alkaline pH and with heat. Verify with RP-HPLC and LC-MS (+0.98 Da deamidation; +17.03 Da open-Gln impurity).
- A280 cannot measure ARA-290. It has no Trp or Tyr. Use A205 or A214 with a sequence-specific coefficient, or a validated HPLC method.
Contents
- What ARA-290 is, chemically
- Charge and pI, recomputed with three pKa sets
- Why it clouds: the mechanism
- What supplier datasheets actually say
- Phosphate buffer systems for acidic peptides
- The buffer-capacity trap: why PBS sometimes fails
- Solvent decision tree
- Laboratory methods
- Troubleshooting table
- Chemical stability: Asn9 deamidation and the pGlu terminus
- Verification: aggregation vs degradation
- Storage
- Myths versus evidence
- How this guide differs from common advice
- Glossary
- FAQ
What ARA-290 is, chemically
ARA-290 is an 11-residue linear synthetic peptide. It is also called cibinetide, pyroglutamate helix B surface peptide (pHBSP) and PHBSP. Its sequence is modelled on a surface region of erythropoietin, but at about 1.26 kDa it is a small peptide, not a protein.[3][5][6] For the receptor background, see What Is ARA-290. This guide covers only its physical chemistry.
| Property | Value | Source |
|---|---|---|
| Sequence | pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH ({Glp}-EQLERALNSS) | [5][2] |
| Formula / MW | C51H84N16O21; 1257.3 g/mol (free acid); monoisotopic 1256.600 Da (calculated) | [5][3] |
| Identifiers | CAS 1208243-50-8; UNII 9W5677JKDA; PubChem CID 91810664 | [5][6] |
| Usual salt form | Acetate (Cayman writes ·XCH3CO2H, so the acetate content varies by lot) | [3] |
| Ionisable groups | Basic: Arg6 only. Acidic: Glu2, Glu5 and the C-terminal carboxyl. The N-terminus is a lactam and is not ionisable | Sequence |
| Chromophores | No Trp, Tyr, Phe, Cys or Met. There is effectively no A280 signal | Sequence |
| Chemically labile motifs | Asn9–Ser10 (deamidation, backbone cleavage); Gln3 (slow deamidation); the pGlu lactam (very slow ring opening) | [14][15] |
| Hydrophobic residues | Leu4, Leu8 and Ala7: a modest hydrophobic content | Sequence |
Charge and pI, recomputed with three pKa sets

Method. Net charge z(pH) is the sum of Henderson–Hasselbalch terms for the four ionisable groups: +1 for Arg6, −1 for the C-terminal carboxyl, and −1 for each of the two Glu side chains. The pyroglutamate N-terminus contributes nothing. It is a five-membered lactam (an internal amide), not an amine. We solved z(pH) = 0 by bisection to get the pI. To show how much the result depends on assumptions, we used three standard pKa sets plus a fourth, the averages measured in folded proteins:[10][11][12][13]
| pKa set | C-term | Glu | Arg | pI | z at pH 3 | z at 4 | z at 5 | z at 6.5 | z at 7.4 | z at 8 |
|---|---|---|---|---|---|---|---|---|---|---|
| Lehninger | 2.34 | 4.25 | 12.48 | 3.13 | +0.07 | −0.70 | −1.70 | −1.99 | −2.00 | −2.00 |
| EMBOSS (Epk.dat)[11] | 3.6 | 4.1 | 12.5 | 3.61 | +0.65 | −0.60 | −1.74 | −1.99 | −2.00 | −2.00 |
| Bjellqvist (ExPASy)[10][12] | 3.55 | 4.45 | 12.0 | 3.80 | +0.71 | −0.26 | −1.53 | −1.98 | −2.00 | −2.00 |
| Grimsley 2009 averages[13] | 3.3 | 4.2 | 12.3 | 3.55 | +0.55 | −0.61 | −1.71 | −1.99 | −2.00 | −2.00 |
A common calculator error. Most online pI tools assume a free N-terminal amine. If you paste QEQLERALNSS or EEQLERALNSS, you get a pI of about 4.3–4.5 and a charge of only −1 at pH 7. That describes a different molecule, the uncyclised open-Gln impurity. For real ARA-290 the N-terminus must be set to ‘blocked’. Our calculation predicts that the open-Gln impurity is noticeably less charged at neutral pH. We have no data on whether that makes it less soluble, so treat that as a hypothesis.
Reading the numbers. All four sets agree on the important points. Charge is fully developed (−2) from about pH 6.5 upward, falls to about −1 in the pH 4.2–4.6 region, and reaches zero somewhere between pH 3.1 and 3.8. The exact pI is uncertain, but the solvent rule is not. Keep the solution well above pH 6.
Why it clouds: the mechanism
Peptides are least soluble near their pI, where net charge is small and molecules stop repelling each other. Bachem’s rule of thumb classifies peptides by counting charges: acidic peptides go into basic or buffered media, and basic peptides go into acid.[8][9] ARA-290 has a net of −2 charges at neutral pH (three acids, one base), so it is clearly acidic.
Why does it misbehave in plain water if pH 7 is fine? Because plain water does not stay at pH 7 once the peptide is in it. A lyophilised acetate-salt peptide is a weak acid. As it dissolves, its glutamate and C-terminal carboxyls release protons. Unbuffered water has no capacity to absorb them, so the pH drifts toward the pKa of the carboxyls, roughly 4–4.5. There, by the table above, the charge is only about −0.3 to −1.3. Bacteriostatic water behaves the same way. It is unbuffered, labelled pH 4.5–7.0 (typically 5.7), and contains 0.9% benzyl alcohol.[25] The low charge, a little Leu/Ala hydrophobic surface and a high local concentration at the wetting front are enough to produce haze or a gel skin. The peptide is self-acidifying. That is our mechanistic interpretation, and it fits every supplier datum below.
What supplier datasheets actually say
| Supplier (catalogue) | Solvent | Reported figure | Notes |
|---|---|---|---|
| MedChemExpress HY-P0168[1][2] | Water, pH adjusted to 8 with NH3·H2O | 66.67 mg/mL (53.03 mM) | The highest published aqueous figure. It is for water at a controlled pH, not plain water |
| MedChemExpress[1][2] | 0.1 M NaOH | ≥ 50 mg/mL (39.77 mM) | ‘≥’ means saturation was not reached. Strong base is a solubility test, not a storage solvent (see stability) |
| MedChemExpress[1][2] | DMSO | ≥ 34 mg/mL (27.04 mM) | Use newly opened DMSO; hygroscopic DMSO lowers solubility |
| MedChemExpress[1][2] | PBS | 2.5 mg/mL (1.99 mM) | Clear only with sonication, warming and heating to 37 °C |
| Cayman 34943 (acetate)[3][4] | DMSO | ≈ 5 mg/mL | Purge solvent with inert gas. No aqueous figure given. Solid ≥ 4 years at −20 °C |
| TargetMol TP1195 | DMSO | 34 mg/mL (27.04 mM) | Sonication recommended. Powder −20 °C 3 years; in solvent −80 °C 1 year. Read from the TargetMol product page and datasheet on 2026-10-29; the site blocks automated link checks, so we give no link |
| Published formulation vehicle[7] | 20 mM sodium phosphate, pH 6.5, 1% sucrose, 4% D-mannitol | n/a | Cited only as evidence of a phosphate-buffered, near-neutral aqueous environment |
Three conclusions. First, the gap between 66.67 mg/mL at controlled pH 8 and 2.5 mg/mL in PBS is enormous. It is the same molecule in the same water, so the difference is pH control, which points to the buffer-capacity effect explained below. Second, the DMSO figures disagree almost sevenfold (≈ 5 vs ≥ 34 mg/mL). A likely reason is salt form and residual water in the lot. For any DMSO stock, plan around the lower number unless your batch says otherwise. Third, no supplier gives a figure for plain water or bacteriostatic water, and that is the condition most guides recommend.
Phosphate buffer systems for acidic peptides
Phosphate is the default buffer for dissolving acidic peptides near neutral pH. The second dissociation, H2PO4− ⇌ HPO42− + H+, has a thermodynamic pKa2 of about 7.2. At physiological ionic strength the apparent value is about 6.8–6.9. A buffer works best within about ±1 pH unit of its pKa, so phosphate covers exactly the pH 6–8 window where ARA-290 is fully charged.
Choosing the pH: 6.5, 7.4 or 8?
| Target pH | HPO42− fraction (pKa 7.2) | β per 20 mM phosphate (mM/pH) | ARA-290 charge | Assessment |
|---|---|---|---|---|
| 6.0 | 0.06 | 2.6 | −1.94 | Charge is fine but capacity is poor; the pH drifts down easily |
| 6.5 | 0.17 | 6.4 | −1.99 | The formulation-vehicle choice. Fully charged, and Asn deamidation is slower than at 7.4–8[7][15] |
| 7.0–7.4 | 0.39–0.61 | 10.9–11.5 | −2.00 | Maximum capacity. Good default for in-vitro work |
| 8.0 | 0.86 | 5.4 | −2.00 | Highest solubility, but capacity falls and deamidation and cleavage are fastest[15] |
There is a real trade-off. Higher pH gives more charge margin and faster dissolution, while lower pH slows the main chemical degradation route (next sections). pH 6.5–7.4 is the sensible middle ground for an aqueous stock. pH 8 is useful for dissolving a concentrated stock quickly, followed by dilution into a pH 6.5–7.4 buffer.
Sodium vs potassium phosphate
| Property | Sodium phosphate | Potassium phosphate |
|---|---|---|
| Behaviour at room temperature | Equivalent buffering | Equivalent buffering |
| Freezing | Na2HPO4·12H2O crystallises first. The pH can fall from 7.4 to about 4 in the freeze-concentrate, which for ARA-290 is close to its pI[21][22][23] | No comparable crystallisation; the pH changes are small (reported shifts of up to about +0.3)[23] |
| Practical consequence | Fine for solutions used fresh or kept at 2–8 °C. For frozen aliquots, use low phosphate concentration and flash-freeze | Preferred when aliquots will be frozen and thawed |
| Other issues | Precipitates with Ca2+/Mg2+ (affects cell-media additions) | Same; K+ is relevant in some cell assays |
This freezing effect is the most underrated point in ARA-290 handling. A stock that was perfectly clear in sodium phosphate at pH 7.4 can pass through a pH 4 freeze-concentrate on the way to −20 °C. That is slow freezing, high salt and an acidic peptide together. If thawed aliquots show haze, consider this mechanism before blaming the peptide.
PBS composition and ionic strength
| Component (1× PBS, common recipe) | mM |
|---|---|
| NaCl | 137 |
| KCl | 2.7 |
| Na2HPO4 | 10 |
| KH2PO4 | 1.8 |
| Total phosphate | ≈ 11.8 |
| Ionic strength (calculated) | ≈ 170 |
| Osmolarity (ideal, calculated) | ≈ 310 mOsm/L |
PBS is mostly saline: about 92% of its ionic strength comes from NaCl, and only about 12 mM is buffer. Salt has two opposing effects on a charged peptide. It screens the repulsion that keeps chains apart, which can promote association, but it also stabilises the charged form. For a small, doubly charged peptide well away from its pI, the buffer’s ability to hold the pH matters far more than the salt. That is why plain 20–50 mM sodium or potassium phosphate without NaCl often dissolves acidic peptides at least as well as PBS. We have no head-to-head ARA-290 data on salt effects, so this point is reasoned from general principles[19].
The published formulation vehicle
The vehicle described in a peer-reviewed study of a Bachem-made batch was 20 mmol/L sodium phosphate, pH 6.5, 1% sucrose and 4% D-mannitol.[7] Read chemically, each component has a clear role. Phosphate at pH 6.5 keeps the peptide at about −2 charge while staying on the slow side of the deamidation curve. Sucrose and mannitol are classic lyoprotectant and bulking or tonicity agents. We cite it only as evidence that a phosphate buffer near pH 6.5 is a suitable chemical environment for this molecule, not as a protocol.
The buffer-capacity trap: why PBS sometimes fails
This is our original analysis. We modelled the full charge balance of a phosphate buffer after adding ARA-290 supplied as an acetate salt, with the carboxyls initially protonated. As each molecule dissolves and its two Glu and C-terminal carboxyls ionise, it releases up to about 2 protons net, and the buffer has to absorb them. At 1 mg/mL the peptide is 0.80 mM, which means up to about 1.6 mM of acid. That is small against 50 mM phosphate, but substantial against the 11.8 mM in 1× PBS.
| Buffer (starting pH) | 1 mg/mL | 2.5 mg/mL | 5 mg/mL | 10 mg/mL |
|---|---|---|---|---|
| 1× PBS (7.4) | 7.1 | 6.8 | 6.0 | 4.4–4.6 |
| 1× PBS (6.5) | 6.2 | 5.0–5.2 | 4.2–4.5 | 3.8–4.1 |
| 20 mM NaPi (7.4) | 7.2 | 7.0 | 6.7 | 5.4–5.5 |
| 20 mM NaPi (6.5) | 6.3 | 6.0 | 4.7–4.9 | 4.1–4.4 |
| 50 mM NaPi (7.4) | 7.3 | 7.2 | 7.1 | 6.8 |
| 100 mM NaPi (7.4) | 7.4 | 7.3 | 7.2 | 7.1 |
The table explains the forum reports that a vial in PBS was ‘90% better but still snowy’. The usual 10 mg vial in 1 mL of PBS ends up near pH 4.5, where the calculated charge is only about −1. It also explains why MedChemExpress needed heat and sonication to reach 2.5 mg/mL in PBS. Practical rule: above about 2 mg/mL, use ≥ 50 mM phosphate, or dissolve in a small volume at pH 8 and then dilute into buffer. Either way, measure the final pH with a micro-electrode or narrow-range strip.
Solvent decision tree

- Step 1. What is the end use? Aqueous assay → Step 2. An assay that tolerates DMSO and needs a concentrated stock → Route C.
- Step 2. Target concentration ≤ 2 mg/mL? Yes → Route A, using a phosphate buffer at pH 6.5–7.4 (PBS is acceptable at this level). No → Step 3.
- Step 3. Above 2 mg/mL: use Route A with 50–100 mM phosphate, or Route B (water brought to about pH 8 with dilute ammonia, then dilution into buffer).
- Step 4. After dissolution: measure the pH. If it is below 6, add a small amount of a concentrated phosphate stock at pH 7.4 rather than more water.
- Step 5. Still hazy at pH ≥ 6.5 and ≤ 1 mg/mL? Stop, and go to the verification section. That points to a material problem, not a solvent problem.
- Never: acetic acid, TFA or other acids; unbuffered water as the first liquid at high concentration; uncontrolled bases such as kitchen bicarbonate.
Laboratory methods
Route A: phosphate buffer (default)
- Equilibrate the sealed vial and the buffer to room temperature, then tap the powder down.
- Base the volume on the net peptide content in the COA, not the gross powder weight. The acetate counter-ion and water are part of the weight.
- Add the buffer down the vial wall. For more than about 2 mg/mL use 50–100 mM phosphate (sodium or potassium), pH 7.0–7.4.
- Let it stand 5–10 minutes, then roll or swirl gently. Do not vortex hard or shake; air–water interfaces promote aggregation.[19]
- If haze persists, use brief warming (≤ 37 °C, a few minutes) or short bath-sonication pulses, as MedChemExpress describes.[1] Keep heat exposure short (see stability).
- Measure the pH, then filter through a low-binding 0.22 µm membrane if sterility is needed. Quantify before and after filtration (verification section).
Route B: concentrated stock at about pH 8
- Add water to about 70–80% of the target volume.
- Add dilute ammonium hydroxide (about 0.1%) dropwise with gentle swirling, monitoring pH, until clear near pH 8. This mirrors the MedChemExpress condition.[1][9]
- Make up to volume, then dilute promptly into a pH 6.5–7.4 phosphate buffer. Do not store the stock at pH 8: ammonia is a general-base catalyst of Asn deamidation.[15]
Route C: DMSO stock
- Use freshly opened, anhydrous DMSO. Plan for about 5 mg/mL unless your batch data support more.[3][1]
- Dilute stepwise into a stirred buffer of pH ≥ 7, not into water. Water lets the pH drift down as the peptide ionises.
- In cell assays, keep the final DMSO low (commonly ≤ 0.1–0.5%) and include a matched solvent control.
Troubleshooting table
| Symptom | Most likely cause | What to try |
|---|---|---|
| Cloudy immediately in water or bacteriostatic water | Self-acidification toward the pI; no buffer | Switch to phosphate at pH 7–7.4, or add a small volume of concentrated phosphate |
| ‘Snow’ or flakes left in PBS at 5–10 mg/mL | PBS capacity exceeded; pH about 4.5–6 | Measure the pH; raise the phosphate concentration or dilute |
| Clears with warming, re-hazes on cooling | Close to the solubility limit | Lower the concentration or raise the pH margin |
| Haze after thawing a frozen aliquot | Sodium phosphate freeze-concentrate acidification[22] | Use potassium phosphate or lower phosphate for frozen aliquots; flash-freeze |
| Precipitate when the DMSO stock is diluted | Diluted into unbuffered water or too quickly | Dilute stepwise into stirred buffer at pH ≥ 7 |
| Cloudy after a ‘helpful’ acid additive | pH pushed to about 3–4, the pI | Remove the acid; re-buffer at pH ≥ 7 |
| Foam or microbubbles | Agitation | Let stand; microbubbles clear within minutes, true haze does not |
| Hazy at ≤ 1 mg/mL in 50 mM phosphate, pH 7.4 | Probable material issue (impurities, wrong salt, wrong identity) | Stop. Run the verification steps and check the COA |
Chemical stability: Asn9 deamidation and the pGlu terminus
Asn9–Ser10 is the hotspot. At neutral and alkaline pH, Asn deamidates through a five-membered succinimide intermediate. The rate is controlled mainly by the residue after the Asn. Gly is fastest, Ser is next, and bulky residues are much slower.[15][16] Robinson and Robinson list primary-structure half-lives of about 6–32 days for Asn-Ser, Asn-His and Asn-Ala sequences in pH 7.4 Tris at 37 °C. They add that phosphate and similar solutes typically speed deamidation two- to threefold compared with Tris.[14] Tyler-Cross and Schirch found three more points that matter for ARA-290.[15]
- Succinimide hydrolysis gives isoAsp and Asp products in about a 3:1 ratio at neutral and alkaline pH. In acid, direct hydrolysis gives only Asp.
- Every Asn-Ser peptide also underwent backbone cleavage at neutral and alkaline pH, at about 10% of the deamidation rate. For ARA-290 that would split off the C-terminal Ser-Ser.
- Small bases such as ammonia act as general-base catalysts. That is why a pH 8 ammonia stock should be diluted and buffered promptly rather than stored.
ARA-290’s residue before Asn is Leu, and that preceding residue has little effect on rate at neutral pH.[15] Combining these data, our estimate is days-to-weeks half-lives at 37 °C and pH 7.4. The rate falls steeply on refrigeration and freezing, and roughly tenfold per unit of pH below 8 in the base-catalysed region. That is an inference from model peptides; no ARA-290-specific kinetic data have been published.
Gln3 deamidates far more slowly than Asn and is a minor concern at the bench.[14] The pGlu N-terminus is the end product of Gln or Glu cyclisation and is chemically robust. Studies on N-terminal Glu and Gln show that cyclisation proceeds spontaneously over months at 37–45 °C. For Glu it is fastest at pH 4 and 8 and slowest near pH 6.2; for Gln it depends more on temperature and buffer than on pH.[17][18] For ARA-290, the practical relevance is analytical. Incomplete cyclisation during synthesis leaves an open-Gln impurity at +17.03 Da. Ring opening of pGlu by hydrolysis (+18.01 Da) needs harsh acid or base and is not expected under bench conditions.
| Condition | Physical (charge/solubility) | Chemical (Asn9) | Verdict |
|---|---|---|---|
| pH 3–4 (acid diluents) | Near the pI: poor | Slow deamidation, Asp only | Avoid (solubility) |
| Unbuffered water (drifts to 4–5) | Charge about −0.5 to −1.5: marginal | Slow | Avoid at high concentration |
| pH 6.5 phosphate | −2: good | Slower than at 7.4 | Best balance |
| pH 7.4 phosphate | −2: good | Moderate; phosphate catalyses somewhat[14] | Good; use fresh, or freeze in aliquots |
| pH 8 (ammonia) | −2: best dissolution | Fastest; ammonia catalysis[15] | Short-lived stock only |
| 0.1 M NaOH | Very high solubility | Rapid base-catalysed degradation expected | A datasheet test, not a solvent |
| 37 °C or sonication heat | Speeds dissolution | Speeds every reaction | Minutes only |
Verification: aggregation vs degradation
A clear vial does not prove the peptide is intact, and a hazy vial does not prove it is ruined. These are the tools, matched to the question each one answers.
| Question | Method | What to look for |
|---|---|---|
| How much peptide is actually in solution? | Centrifuge (≥ 10,000 g, 10 min), then measure the supernatant at A205 or A214, not A280 | Recovery vs the nominal value. ARA-290 has no Trp or Tyr, so A280 reads almost nothing. Anthis & Clore’s sequence method gives ε205 of roughly 31,000–33,000 M−1cm−1 (our estimate; pGlu lactam treatment uncertain), so 1 mg/mL ≈ A205 of about 25 per cm. Dilute heavily and use a buffer blank (phosphate absorbs little at 205 nm; avoid carboxylate buffers and DMSO)[20] |
| Is material lost to haze or the filter? | Compare A205 before and after 0.22 µm filtration | A loss of more than about 5–10% suggests insoluble aggregates or membrane adsorption |
| Are there soluble oligomers? | SEC (peptide column) or DLS | Early-eluting species, or a particle population above the monomer size[19] |
| Is the peptide chemically intact? | RP-HPLC at 214 nm | New peaks; deamidation (isoAsp/Asp) products usually elute close to the main peak |
| What changed? | LC-MS intact mass | [M+H]+ 1257.61; [M+2H]2+ 629.31; [M−H]− 1255.59 (monoisotopic, calculated) |
| Deamidation? | High-resolution MS | +0.984 Da (2+ ion shifts by only 0.49 m/z, so isotope overlap needs resolution). Does not distinguish isoAsp from Asp; that needs MS/MS or chromatography |
| Open-Gln impurity? | MS | +17.03 Da: [M+2H]2+ 637.82 |
| Asn-Ser cleavage? | MS | Loss of the C-terminal Ser-Ser fragment from the parent; look for the shortened N-terminal piece[15] |
A practical rule: if adding buffer or raising the pH to about 7.4 fully restores clarity and A205 recovery, the haze was physical (charge). If clarity returns but HPLC shows new peaks or MS shows +0.98 Da or truncation, the material has degraded chemically, and clarity is irrelevant. See how to read a peptide COA and what mass spectrometry can and cannot confirm.
Storage
- Solid: sealed and dry at −20 °C. Cayman gives ≥ 4 years; TargetMol gives 3 years at −20 °C; MedChemExpress gives −80 °C for 2 years or −20 °C for 1 year.[3][1]
- Solutions: MedChemExpress lists −80 °C for 6 months or −20 °C for 1 month, sealed. TargetMol lists −80 °C for 1 year in solvent.[1] Make single-use aliquots.
- Freezing buffer: for aqueous aliquots, prefer potassium phosphate or low-molarity sodium phosphate, small volumes and fast freezing.[21][22]
- At 2–8 °C: no ARA-290-specific data exist. Given the Asn-Ser motif, treat refrigerated aqueous solutions as short-term and verify by HPLC if kept.
Myths versus evidence
| Myth | Evidence |
|---|---|
| ‘ARA-290 is hydrophobic, so it needs DMSO.’ | Wrong. It has no aromatic or cysteine residues and only Leu4, Leu8 and Ala7 are hydrophobic. It dissolves to 66.67 mg/mL in water at pH 8.[1] The problem is charge. |
| ‘Add a drop of acetic acid like other peptides.’ | That rule is for basic peptides. Acid moves ARA-290 toward its pI of 3.1–3.8.[8][9] |
| ‘PBS always works.’ | At ≤ 2 mg/mL, usually. At 10 mg/mL, 1× PBS can be overwhelmed and drop to about pH 4.5 (our calculation). |
| ‘Bacteriostatic water is the standard diluent.’ | It is unbuffered (pH 4.5–7.0) and does not hold pH against an acidic peptide.[25] |
| ‘A pinch of baking soda fixes it.’ | Poor lab practice. Food-grade bicarbonate has an unknown mass and purity and is non-sterile. Its pH (about 8.3) drifts upward as CO2 escapes, which means fizzing and an unknown final pH, and the base is unmetered.[26] Use a defined phosphate buffer, or titrated dilute ammonia with a pH reading. |
| ‘If it clears, it’s fine.’ | Clarity says nothing about Asn9 deamidation or cleavage. Verify by HPLC and MS.[15] |
| ‘Heat and sonicate until clear.’ | Brief heating is acceptable; prolonged heat speeds deamidation.[14] |
| ‘Any pI calculator works.’ | Not unless the N-terminus is set to blocked. Otherwise the result (4.3–4.5) describes the open-Gln impurity. |
| ‘A280 checks the concentration.’ | ARA-290 has no Trp or Tyr. Use A205 or A214.[20] |
How this guide differs from common advice
We reviewed the top results for ‘ara 290 reconstitution’, ‘ara-290 pbs’ and ‘cibinetide solubility’. They include vendor reconstitution pages, calculator sites, a peptide database, forum and Reddit threads, and supplier datasheets (MedChemExpress, Cayman, TargetMol, Probechem). Below is the gap matrix (✓ = covered, ✗ = not covered).
| Topic | Vendor / blog guides | Calculator sites | Forums | Supplier sheets | This guide |
|---|---|---|---|---|---|
| Supplier solubility figures | ✗ | ✗ | ✗ | ✓ (own only) | ✓ (all, compared) |
| pI or charge with method (pGlu blocked) | ✗ (or ‘hydrophilic’) | ✗ | ✗ | ✗ | ✓ (4 sets) |
| Why acid fails | ✗ | ✗ | Partial | ✗ | ✓ |
| PBS recommended | Some | ✗ | ✓ | ✓ | ✓ |
| Buffer capacity / final pH | ✗ | ✗ | ✗ | ✗ | ✓ (calculated) |
| Sodium vs potassium phosphate on freezing | ✗ | ✗ | ✗ | ✗ | ✓ |
| Asn-Ser deamidation and cleavage | ✗ | ✗ | ✗ | ✗ | ✓ |
| Analytical verification (A205, SEC, MS m/z) | ✗ | ✗ | ✗ | ✗ | ✓ |
| Free of dosing or administration content | Mostly ✗ | ✗ | ✗ | ✓ | ✓ |
Glossary
- pI (isoelectric point): the pH at which net charge is zero, usually the point of lowest solubility.
- Pyroglutamate (pGlu, Glp): a cyclic lactam formed from N-terminal Gln or Glu. It has no free amine.
- Buffer capacity (β): the moles of strong acid or base needed to change the pH of 1 L by one unit. It is highest at pH = pKa.
- pKa2 of phosphate: about 7.2, or about 6.8–6.9 at physiological ionic strength. It is the H2PO4−/HPO42− equilibrium.
- Ionic strength: I = ½Σc·z². It screens electrostatic repulsion.
- Deamidation: Asn or Gln → Asp/isoAsp or Glu, +0.984 Da.
- Succinimide: the cyclic intermediate of Asn deamidation.
- Freeze-concentration: solute enrichment as ice forms. In sodium phosphate it can acidify the remaining liquid.
- A205/A214: peptide-bond absorbance, used when a molecule has no aromatic residues.
- Net peptide content: the fraction of powder mass that is peptide; the rest is counter-ion and water.
Frequently asked questions
Why does ARA-290 turn cloudy in bacteriostatic or plain water?
ARA-290 is acidic (calculated pI 3.1–3.8). As it dissolves, its carboxyl groups release protons, and unbuffered water lets the pH drift toward 4–5, where the peptide carries only about −1 charge or less. Bacteriostatic water is unbuffered (pH 4.5–7.0) and behaves the same way. A phosphate buffer at pH 6.5–7.4 holds the charge at about −2.
Can I dissolve ARA-290 in PBS?
Yes for laboratory solutions up to about 2 mg/mL. At higher concentrations, 1× PBS (about 12 mM phosphate) may be overwhelmed: by our calculation 10 mg/mL can drop it to about pH 4.5. Use 50–100 mM phosphate or a brief pH 8 step, and measure the final pH. MedChemExpress reports 2.5 mg/mL in PBS with sonication and 37 °C.
Does ARA-290 dissolve in phosphate buffer?
Yes. Phosphate buffers best at pH 6–8, where ARA-290 is fully charged. A published formulation vehicle used 20 mM sodium phosphate at pH 6.5 with sucrose and mannitol. For frozen aliquots, potassium phosphate avoids the acidic freeze-concentrate that sodium phosphate can form.
Is ARA-290 hydrophobic?
No. It has no aromatic or cysteine residues and only two leucines and an alanine. MedChemExpress reports 66.67 mg/mL in water at pH 8. Its solubility is governed by charge and pH.
Can I use acetic acid to dissolve ARA-290?
No. Acetic acid helps basic peptides such as AOD9604. For ARA-290 it lowers the pH toward the isoelectric point and makes haze more likely.
What is the isoelectric point of ARA-290?
About 3.1–3.8 depending on the pKa set (Lehninger 3.13, EMBOSS 3.61, Bjellqvist 3.80), calculated with the pyroglutamate N-terminus treated as uncharged. Calculators that assume a free N-terminal amine give about 4.3–4.5, which describes the open-Gln impurity rather than ARA-290.
What is the solubility of cibinetide in DMSO?
Suppliers disagree: Cayman reports about 5 mg/mL for the acetate salt, while MedChemExpress (≥ 34 mg/mL) and TargetMol (34 mg/mL, with sonication) report more. Plan around the lower figure unless your batch data say otherwise, and use fresh anhydrous DMSO.
Is it safe to use baking soda to dissolve ARA-290?
For laboratory work, kitchen bicarbonate is poor practice. Its purity and amount are uncontrolled, it is not sterile, and its pH drifts as CO2 escapes. A defined phosphate buffer or titrated dilute ammonia with a pH measurement gives a reproducible result.
How stable is ARA-290 in solution?
No compound-specific kinetics are published. Its Asn9–Ser10 motif deamidates and can cleave at neutral to alkaline pH, with half-lives of days to weeks at 37 °C in model peptides, faster in phosphate and with ammonia. Keep solutions cold, near pH 6.5–7.4, aliquoted and frozen, and verify by HPLC or MS.
How do I measure ARA-290 concentration?
Not by A280: it has no tryptophan or tyrosine. Use absorbance at 205 or 214 nm with a sequence-specific extinction coefficient (Anthis and Clore method), or a calibrated RP-HPLC assay.
References
- MedChemExpress. Cibinetide (ARA290), HY-P0168: product page (solubility, solution storage). https://www.medchemexpress.com/ARA290.html
- MedChemExpress. Cibinetide data sheet, HY-P0168 (PDF). https://file.medchemexpress.com/batch_PDF/HY-P0168/Cibinetide-DataSheet-MedChemExpress.pdf
- Cayman Chemical. ARA 290 (acetate), item 34943: product information sheet (PDF). https://cdn.caymanchem.com/cdn/insert/34943.pdf
- Cayman Chemical. ARA 290 (acetate), item 34943: product page. https://www.caymanchem.com/product/34943
- PubChem CID 91810664: Cibinetide, C51H84N16O21. https://pubchem.ncbi.nlm.nih.gov/compound/Cibinetide
- FDA Global Substance Registration System: Cibinetide, UNII 9W5677JKDA. https://precision.fda.gov/uniisearch/srs/unii/9w5677jkda
- Brines M. et al. ARA 290, a nonerythropoietic peptide engineered from erythropoietin… Mol Med 2014;20:658–666 (PMC4365069). Cited only for the composition of the vehicle described in Methods. https://pmc.ncbi.nlm.nih.gov/articles/PMC4365069/
- Bachem Knowledge Center. Peptide solubility. https://www.bachem.com/knowledge-center/peptide-solubility/
- GenScript. Peptide solubility guidelines (PDF). https://www.genscript.com/gsfiles/techfiles/GenScript_peptide_solubility_guidelines.pdf
- Bjellqvist B. et al. The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences. Electrophoresis 1993;14:1023–1031. https://pubmed.ncbi.nlm.nih.gov/8125050/
- EMBOSS data file Epk.dat: pK values used by
iep(mirror of the EMBOSS source). https://raw.githubusercontent.com/kimrutherford/EMBOSS/master/emboss/data/Epk.dat - ExPASy Compute pI/Mw tool (Bjellqvist pK set). https://web.expasy.org/compute_pi/
- Grimsley G.R., Scholtz J.M., Pace C.N. A summary of the measured pK values of the ionizable groups in folded proteins. Protein Sci 2009;18:247–251. https://pmc.ncbi.nlm.nih.gov/articles/PMC2708032/
- Robinson N.E., Robinson A.B. Protein deamidation. Proc Natl Acad Sci USA 2002;99:5283–5288. https://pubmed.ncbi.nlm.nih.gov/11959979/
- Tyler-Cross R., Schirch V. Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides. J Biol Chem 1991;266:22549–22556. https://pubmed.ncbi.nlm.nih.gov/1939272/
- Geiger T., Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. J Biol Chem 1987;262:785–794. https://pubmed.ncbi.nlm.nih.gov/3805008/
- Chelius D., Jing K., Lueras A. et al. Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. Anal Chem 2006;78:2370–2376. https://pubmed.ncbi.nlm.nih.gov/16579622/
- Dick L.W. Jr, Kim C., Qiu D., Cheng K.C. Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides. Biotechnol Bioeng 2007;97:544–553. https://pubmed.ncbi.nlm.nih.gov/17099914/
- Zapadka K.L. et al. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus 2017;7:20170030. https://pmc.ncbi.nlm.nih.gov/articles/PMC5665799/
- Anthis N.J., Clore G.M. Sequence-specific determination of protein and peptide concentrations by absorbance at 205 nm. Protein Sci 2013;22:851–858. https://pmc.ncbi.nlm.nih.gov/articles/PMC3690723/
- Kolhe P., Amend E., Singh S.K. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation. Biotechnol Prog 2010;26:727–733. https://pubmed.ncbi.nlm.nih.gov/20039442/
- Gomez G., Pikal M.J., Rodríguez-Hornedo N. Effect of initial buffer composition on pH changes during far-from-equilibrium freezing of sodium phosphate buffer solutions. Pharm Res 2001;18:90–97. https://pubmed.ncbi.nlm.nih.gov/11336359/
- Pikal-Cleland K.A., Rodríguez-Hornedo N., Amidon G.L., Carpenter J.F. Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric β-galactosidase. Arch Biochem Biophys 2000;384:398–406. https://pubmed.ncbi.nlm.nih.gov/11368330/
- AAT Bioquest. PBS (phosphate-buffered saline) preparation and recipe. https://www.aatbio.com/resources/buffer-preparations-and-recipes/pbs-phosphate-buffered-saline
- Pfizer (Hospira). Bacteriostatic Water for Injection, USP: description (0.9% benzyl alcohol, pH 5.7, range 4.5–7.0). https://www.pfizermedical.com/bacteriostatic-water/description
- PubChem: Sodium bicarbonate (properties, aqueous pH behaviour). https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-bicarbonate
About the author: Written by the SaiyanMed Research Team from the primary sources listed above. Values marked as calculated come from our own scripts. Related reading: the opposite (basic-peptide) case in the AOD9604 reconstitution guide, and Peptide identity beyond the product name.
Research Use Only
This article covers laboratory and analytical handling of a research reagent for in-vitro use. It is not medical advice and not a protocol for administration to humans or animals. It makes no claims about effects in people.